Challenges and practice pattern of dyslipidaemia management in India during COVID-19 pandemic: A cross-sectional survey

por Abhyankar, Mahesh V., Mate, Pradip Shripat, Revankar, Santosh Y.
Publicado 2020

Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management

por Das, Sambit, Gupta, AK, Bandyopadhyaya, Biplab, Darla, B Harish, Arya, Vivek, Abhyankar, Mahesh, Revankar, Santosh
Publicado 2021

Management of polycystic ovary syndrome among Indian women using myo‐inositol and D-chiro-inositol

por Vyas, Lila, Raiturker, Anagha Pai, Sud, Shilpi, Goyyal, Poonam, Abhyankar, Mahesh, Revankar, Santosh, Walia, Silki
Publicado 2022

Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study

por Iyengar, S. S., Narasingan, S. N., Gandhi, Pramod, Jaipuriar, Navneet, Mahilmaran, Asha, Patil, Sachin, Abhyankar, Mahesh V., Revankar, Santosh
Publicado 2020

Risk Factors and Comorbidities in Young Indian Patients with Hypertension: REAL YOUNG (Hypertension) Study

por Desai, Nagaraj, Unni, Govindan, Agarwala, Rajeev, Salagre, Santosh, Godbole, Sanjay, Dengra, Ashish, Abhyankar, Mahesh V, Revankar, Santosh
Publicado 2021

Real-World Observational Study on Vildagliptin With Insulin (VIL-INS) or Vildagliptin and Metformin With Insulin (VIL-MET-INS) Therapy in Indian Patients With Type 2 Diabetes Melli...

por Panneerselvam, P, Biswas, Dibakar, Singh, Hema, Dilip Kumar, K, Ravi Kumar, P, Kalra, Pramila, Revankar, Santosh, Warrier, Sona
Publicado 2023

Real-World Clinical Experience of Rosuvastatin as a Lipid-Lowering Therapy for Primary and Secondary Prevention of Cardiovascular Events (REAL ROSE)

por Mehta, Ashwani, Jain, Pradeep, Patil, Ravikant, Sashi Kant, T, Indurkar, Sanjiv A, Kota, Sunil Kumar, Revankar, Santosh, Gupta, Amit
Publicado 2022

Efficacy and Safety of a Fixed-Dose Combination of Vildagliptin and Pioglitazone in Indian Patients With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Comparative, Phase III...

por Erande, Suhas, Mukhopadhyay, Jotideb, Dange, Amol, Deogaonkar, Anushka, Birla, Ashish, Doshi, Chetan, Revankar, Santosh, B, Sridhar S, Kumar, Neeraj, Kadam, Pramod V
Publicado 2023

Real-World Clinical Experience on the Usage of High-Dose Metformin (1500-2500 mg/day) in Type 2 Diabetes Management

por Das, Ashok Kumar, Shah, Sanjiv, Singh, Santosh Kumar, Juneja, Archana, Mishra, Niroj Kumar, Dasgupta, Arundhati, Deka, Nilakshi, Abhyankar, Mahesh, Revankar, Santosh
Publicado 2021

Clinical data analysis of telmisartan for hypertension management in Indian population

por Prem Kumar, A, Ghorai, Anirudra, Kriplani, Vasudev, Dash, Rabindra Kumar, Aravinda, J, Shamanna, Paramesh, Sabeer, TK, Hannan, Abdul, Abhyankar, Mahesh, Revankar, Santosh
Publicado 2021

Resurgence of hypertension and cardiovascular diseases in patients recovered from COVID-19: An Indian perspective

por Krishnakumar, Bhaskaran, Christopher, Johann, Prasobh, P. Sunil, Godbole, Shreerang, Mehrotra, Anurag, Singhal, Anurag, Roy, Satrajit, Bhattacharya, Kuntal, Kolte, Narendra, Abhyankar, Mahesh V., Revankar, Santosh
Publicado 2022

REAL-world evidence of risk factors and comorbidities in YOUNG Indian adults with type 2 diabetes mellitus: A REAL YOUNG (diabetes) study

por Saboo, Banshi, Agarwal, Sanjay, Gupta, Sunil, Makkar, Brij, Panneerselvam, A, Sahoo, Abhay Kumar, Ramchandani, G. D., Das, Sambit, Erande, Suhas, Kadam, Yogesh, Abhyankar, Mahesh V., Revankar, Santosh
Publicado 2021